ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

FTC Seeks Additional Info From Teva, Cephalon Regarding Merger

DOW JONES NEWSWIRES Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) and acquisition target Cephalon Inc. (CEPH) each received a request to provide additional information to the U.S. Federal Trade Commission related to a pending $6.8 billion deal between the firms. Israel-based Teva, which trumped a hostile offer from Valeant Pharmaceuticals International Inc. (VRX) in agreeing to buy Cephalon last month, said it had expected the request. The parties have been cooperating with the FTC staff since shortly after the bid was announced, according to Teva, which said it intends to win clearance "as promptly as possible." Teva on Monday said it continues to expect the deal to be completed in the third quarter, following clearance from U.S. and European regulators, as well as winning approval of Cephalon shareholders. Teva's American depositary shares were recently up 0.4% to $49.35 in after-hours trading. -By John Kell, Dow Jones Newswires; 212-416-2480;

Stock News for Valeant Pharma (VRX)
11/25/201511:30:00Prescription Skin Drugs Explode in Costs, Study Shows
11/24/201516:21:51Statement of Changes in Beneficial Ownership (4)
11/24/201509:48:00U.S. Hot Stocks: Hot Stocks to Watch
11/24/201503:02:00Ackman's Pershing Buys More Of Valeant
11/23/201518:20:00Ackman's Pershing Square Boosts Stake in Valeant to 9.9%
11/23/201517:14:20Amended Statement of Beneficial Ownership (sc 13d/a)
11/23/201507:50:00Pfizer and Allergan Strike Huge Inversion Deal
11/22/201520:40:00Pfizer, Allergan Agree to Merge
11/22/201520:37:00Concerns Over Valeant Spread to Other Drug Makers
11/21/201513:00:033 Stocks Wall Street Hates
11/20/201517:43:47EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class...
11/20/201512:44:03Bill Ackman's Pershing Square Hedge Fund Is Hanging On to This...
11/20/201510:30:00VRX Investor Deadline Alert: Law Offices of Howard G. Smith Reminds...
11/20/201510:26:00/C O R R E C T I O N -- Valeant Pharmaceuticals International...
11/20/201510:26:00/C O R R E C T I O N -- Valeant Pharmaceuticals International...
11/20/201508:41:03How 1 Specialty-Drug Maker Hopes to Win Back Investor Trust
11/20/201508:39:03Should You Own Lone Pine Capital's 3 Favorite Stocks?
11/20/201508:00:00Valeant To Hold Investor Day On December 16
11/20/201508:00:00Valeant To Hold Investor Day On December 16

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations